We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




AACC Rebrands to the Association for Diagnostics & Laboratory Medicine

By LabMedica International staff writers
Posted on 24 Jul 2023

The American Association for Clinical Chemistry (AACC, Washington, DC, USA) has announced a name change to the Association for Diagnostics & Laboratory Medicine (ADLM, Washington, DC, USA). More...

The American Association for Clinical Chemistry (AACC, Washington, DC, USA) has announced a name change to the Association for Diagnostics & Laboratory Medicine (ADLM, Washington, DC, USA). This change reflects the association's role as advocate and champion for a larger professional community involved in diagnostics and laboratory medicine, and its worldwide influence.

While the AACC has been a professional home for clinical chemists since its inception, its programs have over time appealed to a variety of specialties that operate within or alongside the clinical lab. As of today, the association broadly serves those working in or in cooperation with the clinical laboratory. The transition from AACC to ADLM was approved on April 21 through a member vote, in which over two-thirds majority favored the name change.

ADLM is committed to promoting better health via laboratory medicine. It unites over 70,000 clinical lab professionals, physicians, researchers, and business leaders worldwide. These individuals are engaged in various fields including clinical chemistry, molecular diagnostics, mass spectrometry, translational medicine, lab management, and other progressive laboratory sciences. Since 1948, ADLM has been instrumental in promoting the shared interests of the field by fostering programs that encourage scientific collaboration, knowledge, expertise, and innovation.

"I'm proud to say that this change has come about by listening to our members and focusing on the best way to ensure a bright future for our profession," said association president Dr. Shannon Haymond. "This name change does not represent a change of direction for the association. Instead, it more accurately reflects an evolution within the field and the association that has long been underway. As we evolve into this new branding, I'd like to emphasize that the goal of the new brand is to broaden our invitation to collaborate, not narrow it."

Related Links:
AACC 
ADLM 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Clinical Chemistry Assay
Sorbitol Dehydrogenase (SDH)
Multi-Chamber Washer-Disinfector
WD 390
New
Gold Member
Pre- Eclampsia Control
Acusera Pre-Eclampsia Control
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.